Proteasome Inhibition Increases the Efficiency of Lentiviral Vector-Mediated Transduction of Trabecular Meshwork
Author(s) -
Zeynep Aktaş,
Hongyu Rao,
Sarah Slauson,
B’Ann T. Gabelt,
Inna V. Larsen,
Rachael Sheridan,
Leonie Herrnberger,
Ernst R. Tamm,
Paul L. Kaufman,
Curtis R. Brandt
Publication year - 2018
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.17-22074
Subject(s) - transduction (biophysics) , mg132 , green fluorescent protein , microbiology and biotechnology , proteasome inhibitor , trabecular meshwork , biology , viral vector , proteasome , gene delivery , cell culture , chemistry , transfection , gene , biochemistry , genetics , recombinant dna , neuroscience , glaucoma
To determine if proteasome inhibition using MG132 increased the efficiency of FIV vector-mediated transduction in human trabecular meshwork (TM)-1 cells and monkey organ-cultured anterior segments (MOCAS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom